Gemcitabine in patients previously treated with platinum-containing chemotherapy for refractory thymic carcinoma: radiographic assessment using the RECIST criteria and the ITMIG recommendations-Reference-Cited by-同舟云学术

Gemcitabine in patients previously treated with platinum-containing chemotherapy for refractory thymic carcinoma: radiographic assessment using the RECIST criteria and the ITMIG recommendations

Published:2015-12-08 Issue:3 Volume:21 Page:531-538
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Okuma Yusuke^ORCID,Hosomi Yukio,Watanabe Kageaki,Takahashi Satoshi,Okamura Tatsuru,Hishima Tsunekazu

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-015-0926-0.pdf

Reference46 articles.

1. Rare Cancers Europe. In: http://www.rarecancerseurope.org/ . Accessed Aug 2015

2. Detterbeck F, Huang J (2011) ITMIG definitions and policies. J Thorac Oncol 6:S1689–S1755

3. Girard N (2012) Chemotherapy and targeted agents for thymic malignancies. Expert Rev Anticancer Ther 12:685–695

4. Ettinger DS, Riely GJ, Akerley W et al (2013) Thymomas and thymic carcinomas: clinical practice guidelines in oncology. J Natl Compr Canc Netw 11:562–576

5. Burris HA 3rd, Moore MJ, Andersen J et al (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15:2403–2413

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

The Effect and Safety of Anti-PD-1 Single/Combination Therapy in Refractory Thymic Carcinoma: A Case-Series Study

;Cancer Management and Research;2020-11

2. Phase II trial of S‐1 treatment as palliative‐intent chemotherapy for previously treated advanced thymic carcinoma;Cancer Medicine;2020-08-19

3. Clinical Outcomes of Second-Line Chemotherapy in Patients with Previously Treated Advanced Thymic Carcinoma: A Retrospective Analysis of 191 Patients from the NEJ023 Study;The Oncologist;2019-11-26